N@N

LPTH, KWEB, PNQI, VGLT, BSPM, APRI, Removed From Naked Short Lists Today

^{Published on 2016-11-01 06:45:27 - WOPRAI}
 

November 1, 2016 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , announced today that these select companies have been After the NASDAQ, AMEX, NYSE, OTCBB and Pinksheet naked short threshold lists. LightPath Technologies Inc. (NASDAQ:LPTH), KraneShares CSI China Internet ETF (NASDAQ:KWEB), PowerShares Nasdaq Internet Portfolio (NASDAQ:PNQI), Vanguard Long (NASDAQ:VGLT), Biostar Pharmaceuticals Inc. (NASDAQ:BSPM), Nexmed Inc. (NASDAQ:APRI). For a complete list of companies on the naked short lists please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to http://www.buyins.net .

LightPath Technologies Inc. (NASDAQ:LPTH) - LightPath Technologies, Inc. designs, develops, manufactures, and distributes optical components and assemblies. The company offers precision molded glass aspheric optics, infrared aspheric lenses, GRADIUM glass lenses, and other optical materials used to produce products that manipulate light. Its products are used in various industries, including defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunications, machine vision and sensors, and other industries. The company sells its products directly to customers in North America and China, as well as through distributors and channel partners in Europe, the United States, and internationally. LightPath Technologies, Inc. was founded in 1985 and is headquartered in Orlando, Florida.. There is a failure to deliver in shares of LPTH

KraneShares CSI China Internet ETF (NASDAQ:KWEB) - KwikWeb.com, Inc. is an Internet holding company engaged in the business of providing domain-name registry operations and services, operating consumer information portals on the Internet and providing facilities management services for commercial real estate owners. The Company operates through its wholly owned subsidiaries, Internet Properties Development Corp. and Faciliforce, Inc., and its majority-owned subsidiary, Basic Fusion, Inc. The Company also seeks to develop and incubate emerging Internet-based businesses. The Company owns minority interests in .KIDS Domains, Inc. and Minority Business Alliance, LLC. KwikWeb.com is a development stage company and has not yet begun revenue-producing operations.

Registry Solutions and Operations

The Company intends to provide distributed-cost registry solutions for operators of country-code top-level and other general top-level domain-name registries. Many registry operators have a need for a registry operations solution that allows them to maintain their databases in an automated fashion, integrate with the network of domain-name registrars and increase scalability as the number of registered domain-names maintained by the registry increases. The Company intends to provide a proprietary software solution that will allow registries of top-level domains (TLDs) to automate their registry databases and increase scalability as their business grows. It is building a system that will be able to service any registry operator and foster advancements within the marketplace. It will also allow TLDs to move to an automated, real-time, standardized system to allow the operators to manage their domain-name registries.

The Company has developed a demonstration version of this basic software solution. This includes Registry Registrar Protocol and Extensible Provisioning Protocol technologies. Since the Company has only recently finished its solution prototype, it has not expended significant resources on marketing.

KwikWeb.com also intends to offer outsourced registry services, turnkey registry solutions, payment gateways for registries, enhanced billing systems and multilingual domain-name services. The Company intends to provide its registry operator clients with customer support for its software solution.

.KIDS Domains seeks to establish a top-level domain that ensures a child-appropriate experience for children on the Internet. .KIDS Domains seek to be the exclusive registry of top-level domain-names with the .kids top-level domain. The Company holds approximately 17.5% of the outstanding capital stock of .KIDS Domains. Its chairman and its president hold, in the aggregate, approximately 71% of the outstanding capital stock of .KIDS Domains. The Company has entered into a letter of intent with .KIDS Domains to acquire the remainder of the outstanding equity.

Through its registrar Website, joedomains.com, KwikWeb.com registers second-level domain-names in both the general TLDs and the country-code TLDs, enabling individuals, companies and organizations to establish an identity on the Internet. The Company is generating nominal revenues from its registrar Website. Its customers apply to register second-level domain-names directly through its joedomains.com Website. The Company is not an accredited registrar with ICANN. It processes domain-name registrations through Tucows.com, Inc., an accredited wholesale registrar. The Company intends to introduce new products and services, enhance brand awareness, create distribution channels, offer names in additional domains and expand internationally.

Consumer Information Portals

KwikWeb.com owns and operates several consumer information portals on the Internet, including GasPrices.com, RateShock.net and Incubate.net. The Company recently completed the acquisition of the consumer information portal, Seniors.com. Its consumer information portals provide a place to gather on the Internet to obtain information and discuss issues in which those users have interest. The Company provides portals where users can congregate in an env. There is a failure to deliver in shares of KWEB

PowerShares Nasdaq Internet Portfolio (NASDAQ:PNQI) - The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the NASDAQ Internet IndexSM. The fund generally will invest at least 90% of its total assets in common stocks of Internet companies that comprise the underlying index. The underlying index is designed to track the performance of the largest and most liquid U.S.-listed companies engaged in Internet-related businesses that are listed on one of the three major U.S. stock exchanges. The fund is non-diversified.. There is a failure to deliver in shares of PNQI

Vanguard Long (NASDAQ:VGLT) - The investment seeks to track the performance of a market-weighted government bond index with a long-term dollar-weighted average maturity. The fund employs an indexing investment approach designed to track the performance of the Barclays U.S. Long Government Float Adjusted Index. This index includes fixed income securities issued by the U.S. Treasury and U.S. government agencies and instrumentalities, as well as corporate or dollar-denominated foreign debt guaranteed by the U.S. government, with maturities greater than 10 years. Under normal circumstances, at least 80% of the fund's assets will be invested in bonds included in the index.. There is a failure to deliver in shares of VGLT

Biostar Pharmaceuticals Inc. (NASDAQ:BSPM) - Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People s Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. Its product line also includes 12 other OTC products and 17 prescription-based pharmaceuticals. The company s OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Hernia belt; Tangning capsule; Yizi capsule; Shengjing Capsule; Aoxing Ointment; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People s Republic of China.. There is a failure to deliver in shares of BSPM

Nexmed Inc. (NASDAQ:APRI) - Apricus Biosciences, Inc., a biopharmaceutical company, focuses on the development and commercialization of products and product candidates in the areas of urology and rheumatology. Its lead product is Vitaros, a topically-applied cream formulation of alprostadil used for the treatment of erectile dysfunction. The company s marketing partners for Vitaros include Laboratoires Majorelle, Bracco S.p.A., Hexal AG (Sandoz), Takeda Pharmaceuticals International GmbH, Recordati Ireland Ltd. (Recordati S.p.A.), Ferring International Center S.A. (Ferring Pharmaceuticals), Mylan NV, Neopharm Scientific Limited, Elis Pharmaceuticals Limited, and Global Harvest Pharmaceutical Corporation. It also develops second-generation Vitaros, a proprietary stabilized dosage formulation that is expected to be stored at room temperature conditions; and Fispemifene, a tissue-specific selective estrogen receptor modulator that is in Phase IIb clinical trial to treat secondary hypogonadism, lower urinary tract symptoms, and chronic prostatitis in men. In addition, the company plans to initiate a Phase IIb trial for RayVa to treat Raynaud s phenomenon associated with scleroderma; and develops Femprox, a product candidate for the treatment of female sexual interest/arousal disorder. It operates in Latin America, Europe, and internationally. The company was formerly known as NexMed, Inc. and changed its name to Apricus Biosciences, Inc. in September 2010. Apricus Biosciences, Inc. was founded in 1987 and is headquartered in San Diego, California.. There is a failure to deliver in shares of APRI

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net